Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹91 Cr₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹91 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,186.1 Cr 5% -4.3% -14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5%

-4.3%

-14.1%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses